![Julius A. Vida](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julius A. Vida
Keine laufenden Positionen mehr
Karriereverlauf von Julius A. Vida
Ehemalige bekannte Positionen von Julius A. Vida
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Vida International Pharmaceutical Consultants | Gründer | 11.05.2011 | 10.06.2018 |
Präsident | 01.01.1993 | 10.06.2018 | |
OsteoScreen, Inc. | Direktor/Vorstandsmitglied | - | 10.06.2018 |
Almac Sciences (Scotland) Ltd.
![]() Almac Sciences (Scotland) Ltd. Chemicals: SpecialtyProcess Industries Part of Chemical Synthesis Services Business, Almac Sciences (Scotland) Ltd. is a British company that produces custom peptides and proteins. The company is based in Penicuik, UK. | Direktor/Vorstandsmitglied | - | 10.06.2018 |
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Direktor/Vorstandsmitglied | 01.02.1994 | 27.08.2009 |
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Direktor/Vorstandsmitglied | - | 28.11.2007 |
Orphan Medical, Inc.
![]() Orphan Medical, Inc. Pharmaceuticals: MajorHealth Technology Orphan Medical, Inc. develops and markets pharmaceutical and health care products. The company was founded in 1993 and is located in Minnetonka, MN. | Direktor/Vorstandsmitglied | - | 27.06.2005 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.1993 | 01.01.1993 |
Almac Group Ltd.
![]() Almac Group Ltd. Pharmaceuticals: MajorHealth Technology Almac Group Ltd. manufactures and distributes pharmaceutical products. The firm’s services include diagnostics, API services and chemical development, pharmaceutical development, analytical and solid state services, clinical services, clinical technologies and commercial services. The company was founded by Allen McClay in 2002 and is headquartered in Craigavon, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
FIBROGEN, INC. | Direktor/Vorstandsmitglied | - | - |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Julius A. Vida
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Carnegie Mellon University | Doctorate Degree |
Eotvos Lorand University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Vereinigtes Königreich | 4 |
Ungarn | 2 |
Operativ
Director/Board Member | 8 |
Masters Business Admin | 1 |
Founder | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
FIBROGEN, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private Unternehmen | 7 |
---|---|
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Orphan Medical, Inc.
![]() Orphan Medical, Inc. Pharmaceuticals: MajorHealth Technology Orphan Medical, Inc. develops and markets pharmaceutical and health care products. The company was founded in 1993 and is located in Minnetonka, MN. | Health Technology |
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Almac Group Ltd.
![]() Almac Group Ltd. Pharmaceuticals: MajorHealth Technology Almac Group Ltd. manufactures and distributes pharmaceutical products. The firm’s services include diagnostics, API services and chemical development, pharmaceutical development, analytical and solid state services, clinical services, clinical technologies and commercial services. The company was founded by Allen McClay in 2002 and is headquartered in Craigavon, the United Kingdom. | Health Technology |
Vida International Pharmaceutical Consultants | |
OsteoScreen, Inc. | |
Almac Sciences (Scotland) Ltd.
![]() Almac Sciences (Scotland) Ltd. Chemicals: SpecialtyProcess Industries Part of Chemical Synthesis Services Business, Almac Sciences (Scotland) Ltd. is a British company that produces custom peptides and proteins. The company is based in Penicuik, UK. | Process Industries |
- Börse
- Insiders
- Julius A. Vida
- Erfahrung